3Ponte ML, Keller GA, Di Girolamo G. Mechanisms of drug induced QT interval prolongationj]]. Curr Drug SaL 2010,5 (1) :44-53.
4SimkoJ, Csilek A, KardsziJ .et al . Proarrhythmic potential of antimicrobial agentsj]]. Infection,2008,36(3): 194-206.
5Li EC, EsterlyJS, Pohl S, et al. Drug-induced QT-interval prolongation: considerations for clinicians[J]. Pharmacothera?py,2010,30(7) :684-701.
6Wisialowski T, Crimin K. Engtraku[J, et al. Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythro?mycin, and telithromycin based on analysis of monophasic ac?tion potential duration alternans and cardiac instability[J].J Phannacol Exp Ther,2006,318(1) :352-359.
